… Sara Love is currently a Ph.D. candidate in Chemistry at the University of Minnesota under …
is uncharged at physiological pH and is able to enter both live and dead cells. In live cells it is …

… is also critical for the interpretation of results. The determination of a dosing metric is inherently
complicated because little is … Accordingly, there is little consistency in dosing metrics …

… In early stages (I–III), the pathologic finding is mostly isolated to … Hippocampal pathology is
ubiquitous in AD patients but is … Hippocampal pathology is ubiquitous in AD patients but is not …

Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous
studies; however, a large portion of the genetic risk for this disease remains unexplained. …

The lack of reliable measures of alcohol intake is a major obstacle to the diagnosis and
treatment of alcohol-related diseases. Epigenetic modifications such as DNA methylation may …

We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease (AD)
involving over 16,000 individuals, the most powerful AD GWAS to date. In stage 1 (3,941 …

We sought to identify new susceptibility loci for Alzheimer's disease through a staged
association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease …

… It is unclear whether this is because females and children are less likely to be infected by
SARS-CoV-2 or because Covid-19 is less likely to become symptomatic after infection in these …

… The results of this study suggest that plaque removal is not enough to halt progressive
neurodegeneration in Alzheimer's disease and prompt some intriguing challenges to the amyloid …

… The impact on survival of delays between the onset of symptoms and the start of treatment
is controversial and cannot be studied in randomised controlled trials. We did a systematic …